1. Quality of Life Associated with Nausea and Vomiting from Anthracycline-Based Chemotherapy: A Pooled Data Analysis from Three Prospective Trials
- Author
-
Maggie Cheung, Carol Kwok, Leung Li, Victoria A. Yeo, Christopher C. H. Yip, Joyce J. S. Suen, Alex Molassiotis, Kwan H. Wong, Thomas K.H. Lau, Vivian Chan, Winnie Yeo, Elizabeth Pang, Frankie Mo, Vicky T.C. Chan, and Kwai T Lai
- Subjects
Data Analysis ,Cancer Research ,medicine.medical_specialty ,Cytotoxic ,medicine.drug_class ,Nausea ,Vomiting ,Functional Living Index–Emesis ,chemistry.chemical_compound ,Breast cancer ,Quality of life ,Internal medicine ,Nausea and vomiting ,medicine ,Netupitant ,Antiemetic ,Humans ,Anthracyclines ,Prospective Studies ,Prospective cohort study ,Aprepitant ,business.industry ,Palonosetron ,humanities ,Oncology ,chemistry ,Symptom Management and Supportive Care ,Quality of Life ,medicine.symptom ,business ,medicine.drug - Abstract
Background There is limited work on the impact of chemotherapy‐induced nausea and vomiting (CINV) on quality of life (QoL) in adriamycin‐cyclophosphamide (AC)–treated patients with breast cancer. The objectives of the study were the following: (a) to confirm if symptoms of CINV led to lower QoL during AC; (b) to evaluate the pattern of changes in patients’ QoL during multiple cycles of AC; and (c) to assess if the QoL in an earlier cycle affected the QoL in subsequent cycles of AC. Materials and Methods This is a secondary pooled data analysis that included 303 Chinese patients with breast cancer who received 1,177 cycles of adjuvant AC in three prospective antiemetic studies. QoL data were based on Functional Living Index–emesis (FLIE) scored over three to four AC cycles. CINV symptoms assessed included “no significant nausea” (NSN), “significant nausea” (SN), “no vomiting” (NoV), “vomiting” (V), and complete response (CR). Results Across all AC cycles, the mean scores for the FLIE nausea domain for patients who experienced NSN versus SN were 10.92 versus 53.92, respectively (p, This article focuses on chemotherapy‐induced nausea and vomiting and quality of life of breast cancer patients through multiple cycles of treatment.
- Published
- 2021